ClinConnect ClinConnect Logo
Search / Trial NCT05480930

Improving Nighttime Access to Care and Treatment; Part 4-Haiti

Launched by UNIVERSITY OF FLORIDA · Jul 27, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Digital Clinical Decision Support

ClinConnect Summary

This clinical trial, titled "Improving Nighttime Access to Care and Treatment; Part 4-Haiti," is studying a new way to help children who get sick at night when it's hard to find medical help. In areas where healthcare is limited, children can suffer if they can't get timely care, leading to more serious health issues. The trial is testing a telemedicine and medication delivery service (TMDS) along with a digital tool that helps healthcare providers follow medical guidelines better. The goal is to see if using this tool improves the care children receive during those critical nighttime hours.

To participate in this study, children must be 10 years old or younger and have an acute illness (a sudden illness that needs attention). Their parent or guardian needs to contact the TMDS during its operating hours. Parents or guardians will also need to agree to certain consent requirements, which can vary depending on how they are contacted. If you decide to participate, you can expect to be involved in a system that aims to improve nighttime healthcare for your child, helping ensure that they receive the best possible support when they need it most.

Gender

ALL

Eligibility criteria

  • Inclusion criteria for child, parent/guardian participants:
  • Children 10 years of age or younger with an acute illness
  • Parent/guardian contacts the TMDS in regards to the illness during hours of operation
  • Parental/guardian agreement to a waiver of documentation of consent when contact is by phone only OR written consent/assent at the household from the parent/guardian and child (7yrs and older) for participants who receive a household visit.
  • Exclusion criteria for child, parent/guardian participants:
  • No consent

About University Of Florida

The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.

Locations

Gressier, Ouest, Haiti

Patients applied

0 patients applied

Trial Officials

Eric J Nelson, MD PhD

Principal Investigator

University of Florida

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials